Trial Profile
A Randomized, Open-label, Multiple Dose, 2-way Crossover Study to Evaluate the Drug Drug Interaction of CKD-501 and D308 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Feb 2020
Price :
$35
*
At a glance
- Drugs Lobeglitazone (Primary) ; Pyridines (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 25 Jan 2020 Results assessing the effect of the coadministration of lobeglitazone and dapagliflozin on their individual pharmacokinetic properties at steady state in healthy male volunteers in the fasted statepublished in the Clinical Therapeutics
- 15 Nov 2018 Status changed from recruiting to completed.
- 16 Aug 2018 New trial record